Lisa K. Jennings

Affiliations: 
Cell Biology and Biochemistry University of Tennessee Health Science Center, Memphis, TN, United States 
Area:
Cell Biology, Oncology
Google:
"Lisa Jennings"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Curry BJ, Rikken AOFS, Gibson CM, et al. (2023) Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation. Journal of Thrombosis and Thrombolysis
Franchi F, Rollini F, Faz G, et al. (2020) Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC Study. Journal of the American Heart Association. 9: e015865
d'Alessandro E, Becker C, Bergmeier W, et al. (2020) Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis. Thrombosis and Haemostasis. 120: 538-564
Franchi F, Rollini F, Kairouz V, et al. (2019) Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study. Jacc. Basic to Translational Science. 4: 763-775
Bhatt DL, Pollack CV, Weitz JI, et al. (2019) Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers. The New England Journal of Medicine
Jennings L, Curry BJ, Bhatt DL, et al. (2019) 2350Evaluation of the pharmacodynamics of a ticagrelor reversal agent PB2452 European Heart Journal. 40
Tricoci P, Neely M, Whitley MJ, et al. (2018) Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial. Blood Cells, Molecules & Diseases
Borst O, Münzer P, Alnaggar N, et al. (2018) Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction. Blood Advances. 2: 715-730
Ramsey MT, Fabian TC, Shahan CP, et al. (2016) A prospective study of platelet function in trauma patients. The Journal of Trauma and Acute Care Surgery
Garner JM, Herr MJ, Hodges KB, et al. (2016) The utility of tetraspanin CD9 as a biomarker for metastatic clear cell renal cell carcinoma. Biochemical and Biophysical Research Communications
See more...